Gene · 6281
Papers4,430
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,430
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cornelian Cherry (Cornus mas L.) Extracts Exert Cytotoxicity in Two Selected Melanoma Cell Lines-A Factorial Analysis of Time-Dependent Alterations in Values Obtained with SRB and MTT Assays. | Molecules | 2022 | 35807436 | PubTator, text mining | PubMed |
| SPR-Based Detection of ASF Virus in Cells. | Int J Mol Sci | 2022 | 35806467 | PubTator, text mining | PubMed |
| Structural and Biofunctional Insights into the Cyclo(Pro-Pro-Phe-Phe-) Scaffold from Experimental and In Silico Studies: Melanoma and Beyond. | Int J Mol Sci | 2022 | 35806175 | PubTator, text mining | PubMed |
| Oncolytic adenovirus with MUC16-BiTE shows enhanced antitumor immune response by reversing the tumor microenvironment in PDX model of ovarian cancer. | Oncoimmunology | 2022 | 35800156 | PubTator, text mining | PubMed |
| Exome sequencing in a child with neurodevelopmental disorder and epilepsy: Variant analysis of the AHNAK2 gene. | Mol Genet Genomic Med | 2022 | 35789128 | PubTator, text mining | PubMed |
| S100A10 Is a New Prognostic Biomarker Related to the Malignant Molecular Features and Immunosuppression Process of Adult Gliomas. | World Neurosurg | 2022 | 35779750 | PubTator, text mining | PubMed |
| Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration. | Brain | 2022 | 35776111 | PubTator, text mining | PubMed |
| Digital circadian and sleep health in individual hospital shift workers: A cross sectional telemonitoring study. | EBioMedicine | 2022 | 35772217 | PubTator, text mining | PubMed |
| Multi-block data integration analysis for identifying and validating targeted N-glycans as biomarkers for type II diabetes mellitus. | Sci Rep | 2022 | 35768493 | PubTator, text mining | PubMed |
Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing. | Front Immunol | 2022 | 35757748 | PubTator, text mining | PubMed |
| Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma. | Dis Markers | 2022 | 35756491 | PubTator, text mining | PubMed |
| A Regional Pooling Intervention in a High-Throughput COVID-19 Diagnostic Laboratory to Enhance Throughput, Save Resources and Time Over a Period of 6 Months. | Front Microbiol | 2022 | 35756046 | PubTator, text mining | PubMed |
| Nature of employment and outcomes for urban labor: evidence from the latest labor force surveys in India. | Indian Econ Rev | 2022 | 35754982 | PubTator, text mining | PubMed |
| Tongue immune compartment analysis reveals spatial macrophage heterogeneity. | Elife | 2022 | 35749158 | PubTator, text mining | PubMed |
| Germacrone induces caspase-3/GSDME activation and enhances ROS production, causing HepG2 pyroptosis. | Exp Ther Med | 2022 | 35747157 | PubTator, text mining | PubMed |
| Biopolymer from Water Kefir as a Potential Clean-Label Ingredient for Health Applications: Evaluation of New Properties. | Molecules | 2022 | 35745016 | PubTator, text mining | PubMed |
| Pathophysiology of Diverticular Disease: From Diverticula Formation to Symptom Generation. | Int J Mol Sci | 2022 | 35743141 | PubTator, text mining | PubMed |
| Molecular Characterization of Cancer Associated Fibroblasts in Prostate Cancer. | Cancers (Basel) | 2022 | 35740605 | PubTator, text mining | PubMed |
| Combined High-Throughput Approaches Reveal the Signals Driven by Skin and Blood Environments and Define the Tumor Heterogeneity in Sézary Syndrome. | Cancers (Basel) | 2022 | 35740513 | PubTator, text mining | PubMed |
| The RAGE/multiligand axis: a new actor in tumor biology. | Biosci Rep | 2022 | 35727208 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6281/papers?page=43